-

Susan G. Komen® Urges Swift Passage of Reintroduced SCREENS for Cancer Act

Legislation to Ensure Access to Life Saving Breast Cancer Care

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today commended members of the U.S. House and Senate for reintroducing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act. The legislation is led by Representatives Joe Morelle (D-NY-25) and Brian Fitzpatrick (R-PA-01).

“The SCREENS for Cancer Act would help enable earlier detection of breast cancer when treatment options are more effective, and the prognosis is better."

Share

The SCREENS for Cancer Act reauthorizes a critical program – the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) – that helps women across the country with low incomes who do not have adequate insurance gain access to timely breast and cervical cancer screening, diagnostic, and treatment services.

“Access to timely, high-quality screening and diagnostic services is critical for saving lives, yet far too many people—especially those without adequate insurance—face delays or are unable to access this essential care,” said Molly Guthrie, VP of Policy & Advocacy at Susan G. Komen. “The SCREENS for Cancer Act would help enable earlier detection of breast cancer when treatment options are more effective, and the prognosis is better. Komen is grateful for the leadership of Congressmen Morelle and Fitzpatrick on this legislation and urges Congress to pass it quickly.”

"Cancer has touched my family in the most personal way, and I know firsthand the fear and uncertainty that comes with a diagnosis,” said Rep. Morelle. “Far too many people—especially those in underserved communities—face barriers to lifesaving screenings that could catch cancer early and save lives. I’m proud to introduce the bipartisan SCREENS for Cancer Act with Rep. Fitzpatrick, which will expand access to breast and cervical cancer screenings, ensuring that more people get the care they need. Early detection saves lives, and no one should go without screenings because of their income or insurance status."

Since its founding in 1991, NBCCEDP-funded programs have served more than 6.4 million individuals across the country and provided more than 16.5 million breast and cervical cancer screening examinations, resulting in the diagnosis of nearly 80,000 invasive breast cancers. The program also provides public education, outreach, patient navigation and care coordination to increase breast and cervical cancer screening rates and reach underserved, vulnerable populations.

“Every year, too many lives are lost because cancer is detected too late. By modernizing and expanding the National Breast and Cervical Cancer Early Detection Program, we are taking a step forward in removing barriers that prevent too many women—especially those in underserved communities—from getting the screenings that could save their lives. As Co-Chair of the House Cancer Caucus, I remain committed to advancing bipartisan solutions that put prevention and access at the forefront, and I thank Rep. Morelle for his partnership in this critical initiative,” said Rep. Fitzpatrick.

This bill had widespread, bipartisan support in the 118th Congress and passed key committees in both the Senate and House of Representatives. Susan G. Komen urges the 119th Congress to pass the SCREENS for Cancer Act without delay. Immediate action is critical to make meaningful progress in the fight against breast cancer and to ensure that all Americans have access to the screenings they need for early, life-saving intervention.

Learn more about Susan G. Komen’s Center for Public Policy at: https://www.komen.org/how-to-help/advocacy/center-for-public-policy/

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Cristobal Martinez
Susan G. Komen
(972) 701-2135
cmartinez@komen.org

Susan G. Komen


Release Versions

Contacts

Cristobal Martinez
Susan G. Komen
(972) 701-2135
cmartinez@komen.org

More News From Susan G. Komen

Lives on the Line: Komen® Speaks Out Against Reconciliation Bill as Millions Stand to Lose Coverage

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, is deeply troubled by passage of the One Big Beautiful Bill Act which implements damaging reforms to federal health insurance programs. The Congressional Budget Office estimates these changes, combined with the failure to renew health care tax credits, could cause nearly 17 million people to lose their insurance coverage, increasing the U.S. uninsured rate by 30%. As a direct result of the action...

Susan G. Komen® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers. The ruling in Braidwood Management, Inc., et al v. Robert Kennedy...

Susan G. Komen® Invests Nearly $11 Million to Accelerate Breakthroughs in Breast Cancer Research

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, announced today that it is awarding $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing the disease. These research grants support 25 cutting-edge projects at 17 prestigious institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future. “We are proud to support these exceptional rese...
Back to Newsroom